TCTR20210703004Enrolling By Invitation4 期
Evaluation of the effect of implementing follow-up care model on self-efficacy and readmission due to infection in patients with pemphigus vulgaris.
Faculty of Nursing and Midwifery(fnm).Tehran.Iran0 个研究点目标入组 80 人开始时间: 2021年7月3日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- Enrolling By Invitation
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16 Years 至 80 Years（—）
- 性别
- All
入选标准
- •Inclusion criteria are: having pemphigus vulgaris that has been approved by the relevant doctor and 6 months have passed since the disease - the patient is aware of his disease - people between 18 to 60 years, alertness, knowledge and full understanding of the Persian language Absence of any mental illness, absence of other chronic diseases affecting the course of the disease (cardiovascular, cancer, etc.) -Lite literacy, having complete hearing, the ability to understand the training given to the patient .
排除标准
- •Exclusion criteria are: unwillingness to continue participating in the study, patient death.
研究者
相似试验
已完成
不适用
Evaluation of the effect of a follow-up program forSMOcessation courses during in-patient REHAbilitation treatmentSmoking addictionMental and Behavioural DisordersISRCTN60878792Refonet (Germany)580
招募中
不适用
Follow You intervention study: Effectiveness of a multidisciplinary training program on daily physical functioning in children and young adolescents with a hereditary connective tissue disorder: a feasibility studyextreme flexibilityHeritable Connective Tissue Disorder10028396NL-OMON50966Academisch Medisch Centrum20
尚未招募
不适用
Immediate KMC neurodevelopmental follow-up study.CTRI/2019/11/021899World Health Organization
尚未招募
不适用
A retrospective study evaluating effectiveness of primary brain radiotherapy with TKI for driver gene mutation-positive advanced non-small cell lung cancer with asymptomatic brain metastases.non-small cell lung cancerJPRN-UMIN000046961Shimane University Hospital300
尚未招募
3 期
Karshyahara lauha a potent herbomineral powder to increase Hb or HemoglobiCTRI/2024/08/071906Dr Sunil Sukumar Shirahatti